REVVITY, INC. (RVTY) Risk Factors
Health CareLatest 10-Q filed Aug 11, 2026Source: SEC EDGAR
WealthWire extracted and classified 26 risk factors from REVVITY, INC.’s latest SEC filing, mapping each to a standardized risk taxonomy so they can be compared across every company and sector. The breakdown below shows how those disclosures distribute across risk categories.
Legal & regulatory
8 factorsFinancial
7 factorsTechnology
4 factorsMarket & business
4 factorsOperations & people
3 factorsRecent key developments
Concrete developments — dated events, named agreements and instruments, legal proceedings — that REVVITY, INC. surfaced in its latest filing.
- Acquired Advanced Chemistry Development Inc.
- Entered a definitive agreement to divest the Immunodiagnostics business in China.
- Senior unsecured revolving credit facility entered into in January 2025.January 2025
- 2028 Notes2028
- 2029 Notes2029
- March 2031 NotesMarch 2031
- September 2031 NotesSeptember 2031
- 2051 Notes2051
- Board declared a quarterly dividend of $0.07 per share for Q2 fiscal 2026, paid in August 2026.August 2026
- Board declared a quarterly dividend of $0.07 per share for Q3 fiscal 2026, payable in November 2026.November 2026
- Total assets included $8.8 billion of net intangible assets as of July 5, 2026.July 5, 2026
Go deeper on RVTY
This page shows the category breakdown of the latest filing. The WealthWire API and dashboard add the full risk-factor text, multi-year trends, sector comparisons, and CSV export — for RVTY and every other S&P 500 company.